On Monday, W W Grainger Inc (NYSE:GWW)’s shares declined -1.71% to $218.14.
Grainger’s IT security team discovered that the company was the subject of a cyberattack and that the intruders were able to access limited information on Grainger’s network. In response, Grainger right away began following its cybersecurity protocol by working with leading cybersecurity experts to investigate the situation; implementing improved security measures; and quickly notifying law enforcement officials. The company has not practiced any service disruptions or outages as a result of the incident.
The initial phase of this ongoing investigation is complete. At this time, Grainger has no evidence there is any impact to customers, suppliers or employees because there is no indication that information such as social security numbers or government identification numbers, banking information or credit/debit card information have been compromised by this incident. However, out of an abundance of caution, Grainger is offering 12 months of complimentary identity protection services to customers and employees.
W.W. Grainger, Inc. operates as a distributor of maintenance, repair, and operating (MRO) supplies; and other related products and services that are used by businesses and institutions primarily in the United States and Canada.
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE)’s shares dropped -6.54% to $0.555.
Yingli Green Energy Holding Company Limited (YGE), one of the world’s leading solar panel manufacturers, recently declared that its partner, Yingli Green Energy Americas, Inc., is partnering with PWRstation Corp., an emerging solar technology company, to offer rapidly deployable, activation-ready transportable PV solutions. The Yingli-energized PWRstation™ GENESIS system will be introduced during the Solar Power International tradeshow at Yingli’s booth, #4221, from September 15th to September 17th.
Fully retractable and transportable, PWRstation products are designed for both grid-connected and off-grid projects ranging from 3 kilowatts to 100 kilowatts. These unique solar solutions are typically installed in less than 30 minutes because they are delivered ready-to-deploy and fully assembled with Yingli Solar panels, wiring, racking, and inverters. Automated deployment can also be comprised of, making activation as simple as the push of a button.
Yingli Green Energy Holding Company Limited, together with its auxiliaries, designs, develops, markets, manufactures, sells, and installs photovoltaic (PV) products in the People’s Republic of China and internationally. The company offers polysilicon ingots and blocks, polysilicon wafers, PV cells, PV modules, and integrated PV systems; and develops and operates solar projects.
At the end of Monday’s trade, Neurocrine Biosciences, Inc. (NASDAQ:NBIX)‘s shares dipped -1.72% to $53.16.
Neurocrine Biosciences, Inc. (NBIX) declared that it has suspended two planned clinical studies of the Company’s CRF antagonist NBI-77860.
The two clinical studies that were halted comprise a single dose study in adolescent females with classic congenital adrenal hyperplasia and a multiple dose study in adults with classic congenital adrenal hyperplasia. The Company had not enrolled any subjects in either study and accordingly, there have been no adverse events stated.
The Company has also been informed by the FDA that the NBI-77860 clinical development program would be placed on partial clinical hold.
Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company’s products in clinical development stage comprise elagolix, which is in Phase III study for endometriosis; elagolix that is in Phase IIb study for uterine fibroids; Corticotropin-Releasing Factor Receptor1 Antagonist, which is in Phase I/II study for congenital adrenal hyperplasia and stress-related disorders; and Vesicular Monoamine Transporter 2 Inhibitor (VMAT2) that is in Phase III study for movement disorders, in addition to Phase I study for tourette syndrome. Its research programs comprise VMAT2 for movement disorders, bipolar disorders, and schizophrenia; gonadotropin-releasing hormone (GnRH) antagonists for men’s and women’s health, and oncology; antiepileptic drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled receptors for other conditions.
Iridium Communications Inc (NASDAQ:IRDM), ended its Monday’s trading session with 1.55% gain, and closed at $6.88.
Iridium Communications Inc. (IRDM) stated financial results for the second quarter of 2015 and updated its full-year 2015 and long-range outlook. Net income was $26.0 million, or $0.21 per diluted share, for the second quarter of 2015, as contrast to $15.0 million, or $0.14 per diluted share, for the second quarter of 2014. Operational EBITDA (“OEBITDA”)(1) for the second quarter was $61.0 million, as contrast to $54.7 million for the preceding-year period, representing a year-over-year enhance of 12% and an OEBITDA margin(1) of 60%. OEBITDA grew largely due to higher government service revenue and lower product warranty costs.
Iridium stated second-quarter total revenue of $101.9 million, which comprised of $78.0 million of service revenue and $23.9 million of equipment, engineering and support revenue. Total revenue declined 1% as compared to the comparable period of 2014, while service revenue grew 2% from the year-ago period. Service revenue, which represents primarily recurring revenue from Iridium’s growing subscriber base, was 77% of total revenue for the second quarter of 2015.
Iridium Communications Inc. provides mobile voice and data communications services through satellite to businesses, the U.S. and foreign governments, non-governmental organizations, and consumers worldwide. It offers postpaid mobile voice and data satellite communications services; prepaid mobile voice satellite communications services; broadband data services; and machine-to-machine services for sending and receiving data from fixed and mobile assets in remote locations to a central monitoring station. The company also provides other services, such as inbound connections from the public switched telephone network, short message services, subscriber identity module, activation, customer reactivation, and other peripheral services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
